| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.71▼ | 3.73▼ | 3.73▼ | 4.14▼ | 3.49▲ |
| MA10 | 3.73▼ | 3.76▼ | 3.83▼ | 3.84▼ | 3.61▲ |
| MA20 | 3.73▼ | 3.87▼ | 4.05▼ | 3.54▲ | 3.74▼ |
| MA50 | 3.79▼ | 4.22▼ | 4.04▼ | 3.68▲ | 3.48▲ |
| MA100 | 3.89▼ | 3.99▼ | 3.69▼ | 3.70▼ | 11.70▼ |
| MA200 | 4.12▼ | 3.65▲ | 3.57▲ | 3.24▲ | 24.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.057▼ | 0.070▲ | 0.072▲ |
| RSI | 27.657▼ | 27.717▼ | 32.704▼ | 49.974▼ | 47.851▼ |
| STOCH | 18.413▼ | 6.066▼ | 4.984▼ | 68.709 | 32.111 |
| WILL %R | -92.857▼ | -98.571▼ | -99.138▼ | -67.456 | -57.000 |
| CCI | -221.177▼ | -86.344 | -112.961▼ | 20.560 | 101.588▲ |
|
Monday, March 09, 2026 03:15 PM
Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained Buy-equivalent ratings from institutional research desks ahead of 2026 ...
|
|
Wednesday, March 04, 2026 04:21 AM
X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that the management team will participate in a fireside chat at the ...
|
|
Monday, March 02, 2026 07:30 AM
Detailed price information for X4 Pharmaceuticals Inc (XFOR-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/03/26 | 3.88 | 4.05 | 3.68 | 3.69 | 216,936 |
| 12/03/26 | 4.27 | 4.27 | 3.87 | 3.88 | 308,374 |
| 11/03/26 | 4.63 | 4.67 | 4.31 | 4.33 | 610,375 |
| 10/03/26 | 4.21 | 4.83 | 4.21 | 4.66 | 1,989,878 |
| 09/03/26 | 3.72 | 4.16 | 3.72 | 4.15 | 589,951 |
| 06/03/26 | 3.65 | 3.86 | 3.65 | 3.76 | 281,487 |
| 05/03/26 | 3.51 | 3.71 | 3.49 | 3.70 | 436,553 |
| 04/03/26 | 3.30 | 3.525 | 3.30 | 3.50 | 416,358 |
| 03/03/26 | 3.37 | 3.45 | 3.25 | 3.33 | 1,194,849 |
| 02/03/26 | 3.315 | 3.435 | 3.235 | 3.40 | 267,022 |
|
|
||||
|
|
||||
|
|